A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients With Advanced/Recurrent Non Squamous NSCLC in Combination of Paclitaxel and Carboplatin
A Randomised, Parallel, Double Blinded Study to Compare the Efficacy and Safety of FKB238 to Avastin® In 1st Line Treatment for Patients With Advanced/Recurrent Non Squamous NSCLC in Combination of Paclitaxel and Carboplatin
The purpose of this research study is to compare the effectiveness and safety of FKB238 against Avastin® in men and women with advanced/recurrent non squamous non-small cell lung cancer
Inclusion Criteria:
Exclusion Criteria:
Other inclusion/exclusion criteria may apply.
Fountain Valley, California 92708, United States
Whittier, California 90603, United States
Joliet, Illinois 60435, United States
Massillon, Ohio 44646, United States
Minsk, Minsk Oblast 220013, Belarus
Sofia, Dobrich 9300, Bulgaria
Fukuyama-shi, Hiroshima, Japan
Sasebo-shi, Nagasaki, Japan
Toruniak, Kuyavian-Pomeranian Voivodeship 87-100, Poland
Kuzmolovskiy, Leningradskaya Oblast' 188663, Russia
Novgorod, Nizhny Novgorod Oblast 603109, Russia